Navigation Links
Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share
Date:10/14/2008

eement, ImClone will become a wholly-owned subsidiary of Lilly.

The complete terms and conditions of the tender offer are set forth in the Offer to Purchase, Letter of Transmittal and other related materials which Lilly and Alaska Acquisition Corporation will file with the SEC on October 14, 2008. In addition, on October 14, 2008, ImClone will file with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC relating to the tender offer. Copies of the Offer to Purchase, Letter of Transmittal and other related materials, including the Solicitation/Recommendation Statement, are available free of charge from Georgeson, Inc., the information agent for the tender offer at (800) 262-1918 (toll free). Wells Fargo Bank N.A. is acting as depositary for the tender offer. The dealer manager for the offer is UBS Securities LLC.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com . C-LLY

This press release contains forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. The company cannot guarantee that the merger described will close or that the company will realize anticipated operational efficiencies following any such merger with ImClone .The current credit market may increase the cost of financing the transaction. There are significant risks and uncertainties in pharmaceutical research and development and there can be no guar
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: ... development of compounds for the treatment of cardiovascular and ... last patient visit in its Phase 2 FDG-PET clinical ... 52 patients and was carried out at five sites ...
(Date:12/3/2009)... Inverness Medical Innovations, Inc. (NYSE: IMA ), a ... health at home through the merger of rapid diagnostics and ... on its Series B Convertible Perpetual Preferred Stock ( IMA-PB). ... stock in an amount per share equal to the quotient ...
(Date:12/2/2009)... Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ... of its fourth quarter and fiscal year 2009 on December ... Following the release, at 4:45 p.m. ET Martek will conduct ... All interested parties may listen to the call live via ...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces that a ... its catalogue: ,, Carbondioxide Incubators - ... http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators are the ... cancer, research, and other applications for providing ...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
... Chairman and Chief Executive Officer James G. Carlson released ... Health Insurance Program (SCHIP), which was signed yesterday by ... start in life, and that happens only when they ... the healthcare they need. President Obama and Congress ...
... Feb. 5 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and ... ONCY ), will present a corporate overview of ... Conference on Monday, February 9, 2009 at 4:30 p.m. ... Bayshore Resort in Vancouver, B.C. from February 8-10, 2009.About ...
... Feb. 5 As states increase the number of ... developing new ways of integrating academic content with content ... One trend that is emerging is the state and ... career and technical education (CTE) courses. A new paper ...
Other Biology Technology:AMERIGROUP Praises Expansion of State Children's Health Insurance Program (SCHIP) 2Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America 2ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes 2ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes 3
(Date:12/3/2009)... BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... biometric identification solutions, announced that a majority of ... today approved the sale of the company,s Law ... the shares voted, 98.6% were cast in favor ...
(Date:12/3/2009)... , Preliminary Press Conference Topics, Last Call! ... museum, Attention PIOs: Sending Press Releases to Fall ... December, News Media registration information , News Media ... Who,s coming, , For important information regarding ...
(Date:12/3/2009)... social snubbing? Your genetics, not your friends, may be at ... opioids, relieve not only physical pain, but also some forms ... of 1000 Biology member Markus Heilig shows that small genetic ... the intensity of people,s responses to social rejection. , ...
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Drug Limits Stomach Trouble in Patients Taking Low Dose Aspirin 50780 1Drug Limits Stomach Trouble in Patients Taking Low Dose Aspirin 50780 2New study pinpoints difference in the way children with autism learn new behaviors 50778 1New study pinpoints difference in the way children with autism learn new behaviors 50778 2New study pinpoints difference in the way children with autism learn new behaviors 50778 3Atrial fibrillation linked to increased hospitalization in heart failure patients 50776 1Atrial fibrillation linked to increased hospitalization in heart failure patients 50776 2
... Hospital (MGH) researchers have developed a new type of ... greatly expand the application of minimally invasive diagnostic and ... Nature, the team from the Wellman Center for Photomedicine ... of its use in a mouse model. ...
... facial similarity of children is effectively an estimate of ... according to a new study recently published in Journal ... Association for Research in Vision and Ophthalmology (ARVO). ... of children, half of which portrayed actual siblings. ...
... varying the length of daylight to which mice are exposed ... , The study found that in the short days ... increase aggression in males of a particular type of mouse ... in the long days of summer, estrogen decreases aggression among ...
Other Biology News:Three-dimensional, miniature endoscope opens new diagnostic possibilities 2Changing length of days reverses how estrogen affects aggressiveness in mice 2Changing length of days reverses how estrogen affects aggressiveness in mice 3Changing length of days reverses how estrogen affects aggressiveness in mice 4
... The FilterMate is a compact, versatile system ... a 96- or 24-well microplates into a ... microplate liquid scintillation and gamma counter. The ... samples for applications such as cell proliferation, ...
... single use spatulas have been designed to ... are for those interested in eliminating the ... Each spatula is individually packaged, RNase/DNase free, ... is a new product number, created to ...
... Progesterone Receptor (PR) Competitor Assay Kits ... novel progesterone receptor binding compounds using ... utilizes a fusion of glutathione transferase ... human progesterone receptor [PR-LBD(GST)] and a ...
... combine the proven features of the pET, ... provides all of the benefits and versatility ... backbone. The pTriEx vectors have been extensively ... in all three expression systems. In each ...
Biology Products: